Pomotrelvir, CAS [[2713437-86-4]]

Produktübersicht

• Artikelname: Pomotrelvir, CAS [[2713437-86-4]]
• Artikelnummer: MCE-HY-153228
• Hersteller Artikelnummer: HY-153228
• Alternativnummer: MCE-HY-153228-5MG,MCE-HY-153228-25MG,MCE-HY-153228-1MG,MCE-HY-153228-10MMX1ML,MCE-HY-153228-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: PBI-0451

Produktbeschreibung

Pomotrelvir is a selective, competitive, orally active covalent inhibitor of the SARS-CoV-2 main protease (Mpro), with an IC50 of 24 nM for wild-type SARS-CoV-2 Mpro. Pomotrelvir inhibits viral polyprotein processing, thereby preventing viral replication. Pomotrelvir has shown broad antiviral activity against multiple SARS-CoV-2 variants (including Omicron) in cell-based experiments, and has an additive effect when combined with nucleoside analogs that target viral RNA synthesis. Pomotrelvir is primarily used for the research and development of COVID-19 antiviral drugs, especially for infections caused by SARS-CoV-2 and its variants[1][2].

Produkteigenschaften

• Molekulargewicht: 455.94
• Reinheit: 96.73
• CAS Nummer: [2713437-86-4]
• Formel: C23H26ClN5O3
• Target-Kategorie: SARS-CoV

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound